
Central Coast group puts economic data within REACH

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Real Estate: Hayes looks back on a year of pandemic; Las Posas Country Club sold
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Amgen shares slip after projections of flat 2021 sales

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
PennyMac reports earnings jump, tops $2B in income in 2020

PennyMac Financial Services hit a record high with pretax income of more than $2 billion last year as the company saw a sharp increase in both its fourth quarter and year-end results. The Westlake Village-based mortgage firm reported a net income of $452.8 million for the fourth quarter of 2020, or $5.97 per share on Read More →
Facebook to give UCSB $1.5M to study data centers

Facebook will give $1.5 million to UC Santa Barbara’s Institute for Energy Efficiency to fund research into energy-efficient data centers and artificial intelligence, UCSB announced Feb. 4. The institute will use the three-year grant to “investigate advanced energy-efficient data center infrastructure, including low-power optical interconnects for computer networks and machine learning with reduced carbon footprint,” Read More →
Amgen reports rising revenue, warns of flat 2021

Amgen, one of the world’s largest biotech companies, saw rising revenue in the fourth quarter of 2020, but the COVID-19 pandemic could dampen the outlook for the company and its investors in 2021, according to earnings released Feb. 2. The Thousand Oaks-based biotech firm had $6.6 billion in revenue in the fourth quarter, a 7% Read More →